Status:
UNKNOWN
Application of hybridAPC in the Treatment of Barrett
Lead Sponsor:
Changhai Hospital
Collaborating Sponsors:
Shanghai Zhongshan Hospital
First Affiliated Hospital of Zhejiang University
Conditions:
Barrett's Esophagus
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of the new technique of HybridAPC in the treatment of Barrett.
Detailed Description
After thermal ablation of Barrett's esophagus, stricture formation is reported in 5 to over 10% of patients. Submucosal fluid injection prior to ablation may lower the risk of stricture formation. The...
Eligibility Criteria
Inclusion
- Patients age is from 18 to 70.
- Patients who were diagnosed with Barrett's esophagus.
- Informed consent.
Exclusion
- Patient with severe cardiopulmonary dysfunction is unable to tolerated by endoscopy.
- Severe bleeding tendency.
- Poor compliance.
- Patient is very ill and life expectancy is less than 2 years.
- Esophageal varices or venous aneurysms, and no effective prevention or treatment for bleeding.
- Severe esophageal stenosis.
- Pregnancy.
- Lesion is located in esophageal diverticulum or spread their diverticulum.
Key Trial Info
Start Date :
December 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 5 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03418584
Start Date
December 5 2017
End Date
December 5 2021
Last Update
February 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Changhai Hospital, Second Military Medical University
Shanghai, Shanghai Municipality, China, 200433